AIs |
Aromatase Inhibitors |
BC |
Breast Cancer |
CDK4/6 |
Cyclin-Dependent Kinase 4/6 |
CDKs |
Cyclin-Dependent Kinases |
ER |
Estrogen Receptor |
ER+ |
Estrogen-Receptor Positive |
ERE |
Estrogen Responsive Element |
FDA |
Food and Drug Administration |
HER2 |
Human Epidermal Growth Factor Receptor 2 |
HPNE |
Human Pancreatic Nestin-Expressing ductal |
INK4 |
INhibitor of CDK4 |
KIP |
CDK-Kinase Inhibitory Protein |
MMP |
Matrix-Metallo-Proteinase |
mTOR |
Mammalian Target Of Rapamycin |
PI3K |
PhosphatidylInositol 3-Kinase |
PR |
Progesterone Receptor |
SERD |
Selective ER Down-regulators |
SERM |
Selective ER Modulators |
SMI |
Small Molecule Inhibitor |
TN |
Triple Negative |